Idiopathic Pulmonary Fibrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 and 75, male and female; 2. Diagnosis according to guidelines of the Idiopathic Pulmonary Fibrosis by ATS/ERS/JRS/ALAT in 2018; 3. In line with the diagnostic criteria of TCM syndrome "Qi and Yin deficiency"; 4. Good ability to read, understand and write research-related materials, and voluntary compliance with all testing requirements; 5. Volunteer for a study, sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with acute exacerbation of IPF or those with FVC% < 50% or those with obvious pulmonary infection should be treated with anti-infection therapy; 2. Patients with chronic obstructive pulmonary disease, interstitial lung disease, active pulmonary tuberculosis, bronchiectasis and other chronic lung diseases that need intervention or treatment; 3. Patients with severe mental and psychological disorders, cardiovascular, liver and kidney, endocrine, hematopoietic system, malignant tumor and other serious primary diseases; 4. Patients who had taken glucocorticoid within 1 month; those who had taken immunosuppressants within 1 month; those who had taken Pirfenidone, Nintedanib or antacid within 1 month; 5. Patients who are unwilling or unable to change the current treatment plan; 6. Patients who are known to be allergic to the test drug or some traditional Chinese medicine in the test drug; 7. Women in lactation, pregnancy or preparing for pregnancy; 8. Patients who have participated in other clinical studies in recent six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced vital capacity;Times of acute exacerbation; | — |
Secondary
| Measure | Time frame |
|---|---|
| SGRQ score;FEV1/FVC;DLCO;BNP;TCM syndrome score; | — |
Countries
China
Contacts
Hospital of Chengdu University of traditional Chinese Medicine